Analystreport

Imprimis Pharmaceuticals (NASDAQ: IMMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.

IMPRIMIS PHARMACEUTICALS  (IMMY) 
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: imprimisrx.com